To clarify whether the JAK2/STAT3 pathway mediates the regulatory effect of circSPARC on CRC progression, we used TG101348, an inhibitor of JAK2/STAT3 signalling (especially JAK2), to conduct rescue assays in circSPARC-overexpressing cells. The gene discussed is JAK2; the disease is colorectal carcinoma.